Pulmatrix, Inc. (PULM)
Last updated: 2026-10-23 17:59:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Pulmatrix, Inc. (PULM) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.46, with a market capitalization of $5.73M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.16 to $4.99. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$5.73M | |
$1.40 | |
$2,910.00 | |
$1.16 | |
$1.42 | |
8.07K | |
26.72K | |
-- | |
$4.99 | |
$1.16 | |
-- | |
-- |
Pulmatrix, Inc. (PULM) Stock Price Today
Pulmatrix, Inc. (PULM) is currently trading at $1.46 as of 2026-10-23 17:41:00, up 2.82% ($0.04) from the previous close of $1.42
During today's regular trading session, PULM has traded between $1.16 and $2,910.00, with a trading volume of 8.07K shares. The current price is near the lower end of today's range.
Pulmatrix, Inc. (PULM) 7-Day Stock Price Change
Over the past seven days, Pulmatrix, Inc. (PULM) moved from $1.37 to $1.46, representing a gain of 6.57% ($0.09).
The stock traded between $1.34 and $1.61 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 36.69 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
PULM 52-Week Price Position
Position in Range: 7.8%
PULM is currently trading at $1.46, placing it 7.8% of the way from its 52-week low of $1.16 to its 52-week high of $4.99. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Pulmatrix, Inc. (PULM)?
Pulmatrix Inc is a biopharmaceutical company focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
Pulmatrix, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Pulmatrix, Inc. (PULM) Stock on MEXC
Eligible investors can buy real shares of Pulmatrix, Inc. (PULM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Pulmatrix, Inc. (PULM) stock price today?
2.Is PULM stock going up or down today?
3.What is PULM pre-market price?
4.What is PULM after-hours price?
5.Is PULM stock trading now?
6.Where does PULM sit relative to its 52-week high and low?
7.What sector is Pulmatrix, Inc. in?
8.What is Pulmatrix, Inc.'s market capitalization and where is it listed?
9.How is PULM valued in terms of P/E ratio and EPS?
10.Does Pulmatrix, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
PULM Stock Calculator
Estimate the value between PULM shares and USD.
PULM Shares to USD
1.00 PULM shares = 1.46 USD
Calculations are estimates based on the latest available price and are for reference only.


